This document discusses identifying high-risk patients for elective non-cardiac surgery. It outlines a stepwise approach to pre-operative cardiac risk assessment recommended by Canadian and European guidelines. This includes assessing clinical risk factors and the type of surgical procedure. It also describes several common risk indices used for perioperative cardiac risk stratification, including the Goldman Cardiac Risk Index, Lee/Revised Cardiac Risk Index, and NSQIP model. The document recommends using clinical risk indices and the NSQIP model or Lee index to stratify risk and describes when biomarker testing may be considered to obtain additional prognostic information for high-risk patients.
Original Description:
Original Title
Identifying high risk patient for elective non cardiac surgery
This document discusses identifying high-risk patients for elective non-cardiac surgery. It outlines a stepwise approach to pre-operative cardiac risk assessment recommended by Canadian and European guidelines. This includes assessing clinical risk factors and the type of surgical procedure. It also describes several common risk indices used for perioperative cardiac risk stratification, including the Goldman Cardiac Risk Index, Lee/Revised Cardiac Risk Index, and NSQIP model. The document recommends using clinical risk indices and the NSQIP model or Lee index to stratify risk and describes when biomarker testing may be considered to obtain additional prognostic information for high-risk patients.
This document discusses identifying high-risk patients for elective non-cardiac surgery. It outlines a stepwise approach to pre-operative cardiac risk assessment recommended by Canadian and European guidelines. This includes assessing clinical risk factors and the type of surgical procedure. It also describes several common risk indices used for perioperative cardiac risk stratification, including the Goldman Cardiac Risk Index, Lee/Revised Cardiac Risk Index, and NSQIP model. The document recommends using clinical risk indices and the NSQIP model or Lee index to stratify risk and describes when biomarker testing may be considered to obtain additional prognostic information for high-risk patients.
• To describe how to assess perioperative cardiac risk using
clinical risk factors and type of surgical procedure • To describe a stepwise approach for pre-operative cardiac risk assessment • To know various risk indices for perioperative cardiac risk • To be easy to use for practitioners Non-Cardiac Surgery – The role of multidisciplinary team Stepwise approach (Canadian Cardiovascular Society Guidelines)
Surgery Surgery • Goldman Cardiac Risk Index • Lee / Revised Cardiac Risk Index • NISQP • Goldman Cardiac Risk Index • Lee / Revised Cardiac Risk Index • NISQP • Goldman Cardiac Risk Index • Lee / Revised Cardiac Risk Index • NISQP Recommendation on Cardiac Risk Stratification • Clinical risk indices are recommended to be used for peri-operative risk stratification. I B • The NSQIP model or the Lee risk index are recommended for cardiac peri- operative risk stratification. I B • Assessment of cardiac troponins in high-risk patients, both before and 48–72 hours after major surgery, may be considered. IIb B • NT-proBNP and BNP measurements may be considered for obtaining independent prognostic information for perioperative and late cardiac events in high-risk patients. IIb B • Universal pre-operative routine biomarker sampling for risk stratification and to prevent cardiac events is not recommended. III C Conclusion • Assessment of perioperative cardiac risk using clinical risk factors and type of surgical procedure • A stepwise approach for pre-operative cardiac risk assessment • Various risk indices for perioperative cardiac risk -Matur Nuwun-